A retrospective study for prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors : a large Italian cohort
Latest Information Update: 01 Jun 2020
At a glance
- Drugs Dolutegravir (Primary) ; Elvitegravir (Primary) ; Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
Most Recent Events
- 01 Jun 2020 New trial record